UnitedHealth Group Inc said on Monday it would buy Diplomat Pharmacy Inc for about $300 million, weeks after the troubled specialty pharmacy company raised doubts about its ability to continue as a going concern.
UnitedHealth's pharmacy services unit, Optum, said it would pay $4 per share in cash for Diplomat's outstanding common stock, representing a 31% discount to the company's closing price on Friday.
Diplomat's shares were trading down 31% at $4 before the bell on Monday.
Earlier this year, Diplomat had said it would review options including putting itself up for sale in the wake of customer losses in its pharmacy benefits management (PBM) business due to intense competition.
The company, which started out in 1975 as a neighborhood pharmacy and also provides specialty pharmacy services, forayed into the PBM business in 2017 with back-to-back purchases of LDI Integrated Pharmacy Services and National Pharmaceutical Services.
UnitedHealth's Optum unit brought in $28.76 billion in the third quarter, while Diplomat's total revenue during the same quarter was $1.30 billion.
The deal has been unanimously approved by Diplomat's board of directors, the companies said in a statement.
美国联合健康集团( UnitedHealth Group Inc .)周一表示,将斥资约3亿美元收购美国外交药房公司(文凭药房 Inc .).几周前,这家陷入困境的专业药房公司对其持续经营能力提出质疑.
UnitedHealth 旗下的药店服务部门 Optum 表示，将以每股4美元的现金收购外交官公司的流通股，较该公司上周五的收盘价有31%的折扣。
今年早些时候，外交官曾表示，由于激烈的竞争，该公司将重新考虑各种方案，包括在客户因药房福利管理（ PBM ）业务出现亏损后自行出售。
公司从1975年开始作为社区药店，同时也提供特色药店服务，2017年通过背对背采购 LDI 综合药店服务和国家药事服务进军 PBM 业务。
联合健康的 Optum 部门在第三季度带来了287.6亿美元，而外交官在同一季度的总收入为13.00亿美元。